Albany Molecular shutters facility in Hungary, axing 100

Albany Molecular Research ($AMRI) has announced plans to close a facility in Budapest, axing 100 jobs in the process. The contract research group and manufacturer says it plans to complete a restructuring in the second quarter. Story

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

The CRO will transfer most of its Pennsylvania-based biologics laboratory functions to a new, 73,000-square-foot site on Devon Park in Wayne.

Monoclonal antibodies developer Xencor extended a strategic alliance formed in 2016 with Selexis with four commercial license agreements.